Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2067-2071
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2067
Table 4 Operative, macroscopic, and microscopic findings of HCC patients with and without ESRD.
ESRD–HCC (%) (n = 26)HCC (%) (n = 1198)P
Major hepatectomy17/26 (65.4)603/1198 (50.3)0.129
Blood loss (cc)955.8±771.21358.6±1593.30.199
Blood transfusion (cc)462.0±580.11037.9±2261.90.204
Tumor size (cm)4.1±2.06.2±4.50.0001
Tumor size >5 cm6/26 (23.1)545/1171 (46.5)0.018
Grading (Edmondson and Stainer)
Low-grade (I+II)10/25 (40.0)504/948 (53.2)
High-grade (III+IV)15/25 (60.0)444/948 (46.8)0.193
Capsule formation (+)16/21 (76.2)676/1012 (66.8)0.365
Capsule invasion (+)8/15 (53.3)359/625 (57.4)0.751
Macroscopic vascular invasion (+)8/24 (33.3)431/1150 (37.5)0.678
Satellite lesions (+)5/25 (20.0)336/1155 (29.1)0.321
Resection margin >1 cm12/23 (52.2)373/1051 (35.5)0.099
Rupture (+)3/26 (11.5)140/1167 (12.0)0.943
Complication11/26 (42.3)240/1198 (20.0)0.005
Hospital stay (d)26.8±11.721.7± 12.70.046
Mortality3/26 (11.5)63/1198 (5.3)0.161